- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Aldo-keto reductase family 1 member C1 (AKR1C1), also known as dihydrodiol dehydrogenase 1 (DDH1), is a cytosolic enzyme that plays a key role in the detoxification of xenobiotics and reactive metabolic intermediates. The AKR1C1 Antibody / Dihydrodiol Dehydrogenase 1 Detoxification Enzyme Antibody is designed for studies focused on cellular defense mechanisms and metabolic processing of endogenous and exogenous compounds. AKR1C1 is encoded on chromosome 10p15 and belongs to the aldo-keto reductase superfamily, which catalyzes NADPH-dependent reduction reactions involved in the metabolism of aldehydes, ketones, and lipid peroxidation products.
The AKR1C1 antibody, also referred to as Dihydrodiol dehydrogenase 1 antibody and DDH1 antibody in the literature, recognizes a protein that is predominantly localized in the cytoplasm. In this context, DDH1 contributes to the detoxification of polycyclic aromatic hydrocarbons and other xenobiotic compounds by converting reactive intermediates into less toxic metabolites. This enzymatic activity is essential for maintaining cellular homeostasis under conditions of oxidative stress and chemical exposure.
This AKR1C1 Antibody / Dihydrodiol Dehydrogenase 1 Detoxification Enzyme Antibody is uniquely positioned for studies of detoxification pathways and metabolic stress responses. In immunohistochemistry, AKR1C1 is typically observed as cytoplasmic staining in hepatocytes and epithelial cells, reflecting its role in intracellular metabolic processing. In western blot analysis, the protein is detected as a band corresponding to its predicted molecular weight, supporting evaluation of expression across tissues and experimental models.
AKR1C1 expression is particularly prominent in liver tissue, where detoxification processes are highly active. The enzyme also participates in the metabolism of endogenous substrates, including steroid hormones, linking detoxification pathways with broader metabolic regulation. In cancer biology, altered AKR1C1 expression has been associated with drug resistance and adaptive metabolic changes, where increased detoxification capacity may contribute to tumor cell survival under therapeutic stress.
The mouse monoclonal clone AKR1C1/9318 provides consistent detection of AKR1C1 in research applications where detoxification and metabolic resilience are of interest. This AKR1C1 Antibody / Dihydrodiol Dehydrogenase 1 Detoxification Enzyme Antibody is suitable for detecting DDH1 expression in studies of xenobiotic metabolism, oxidative stress response, and disease-associated metabolic adaptation. Its performance supports detailed evaluation of enzyme expression across normal and pathological conditions.
This antibody supports investigation of detoxification pathways, metabolic stress responses, and disease-associated changes in AKR1C1 expression.
This antibody can be compared with our AKR1C1 Antibody (clone AKR1C1/9063) for consistent detection of AKR1C1 across steroid metabolism and detoxification studies.
Optimal dilution of the AKR1C1 Antibody / Dihydrodiol Dehydrogenase 1 Detoxification Enzyme Antibody should be determined by the researcher.
A recombinant human full-length AKR1C1 protein was used as the immunogen for the Dihydrodiol dehydrogenase 1 antibody.
Aliquot the Dihydrodiol dehydrogenase 1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
AKR1C1 antibody, Dihydrodiol dehydrogenase 1 antibody, DDH1 antibody, AKR1C1 detoxification enzyme antibody, Aldo-keto reductase family 1 member C1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.